JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details


513 *	Wed, 8/1/2012, 10:30 AM - 12:20 PM	CC-Room 24B
Interim Analysis Methods and Innovations — Contributed Papers
Biopharmaceutical Section
Chair(s): A. Lawrence Gould, Merck
10:35 AM	Multivariate B-Value: A Tool for Monitoring Data with Multiple Co-Primary Endpoints — Yansong Cheng, Boston University ; Surajit Ray, Boston University ; Ying Zhu, Biogen Idec
10:50 AM	An Efficiency Ratio for Criteria Selection in Futility Assessment of Clinical Trials — Jianliang Zhang, MedImmune
11:05 AM	Data Monitoring in Clinical Trials Using Innovative and Practical Bayesian Tool — Soumi Lahiri, GlaxoSmithKline
11:20 AM	Predictive Power for Group Sequential Trials with Different Endpoint at Interim Look — Shengyan Hong, MedImmune ; Songfeng Wang, University of South Carolina
11:35 AM	Predicting the Event Time in Multicenter Clinical Trials with Time-to-Event Outcome as Primary Endpoint — Nibedita Bandyopadhyay, Janssen Pharmaceuticals R&D
11:50 AM	Closed Tests for Multi-Arm Phase II Oncology Trials — Karen Messer, University of California at San Diego ; Hongying Li, University of California at San Diego ; Minya Pu, University of California at San Diego
12:05 PM	The Case for Bayesian Predictive Probabilities for Interim Monitoring of Clinical Trials — Benjamin Saville, Vanderbilt University School of Medicine ; Jason Connor, Berry Consultants ; Gregory Ayers, Vanderbilt University School of Medicine ; JoAnn Alvarez, Vanderbilt University School of Medicine

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.